Literature DB >> 2243124

Transforming growth factor-beta activity in sheep lung lymph during the development of pulmonary hypertension.

E A Perkett1, R M Lyons, H L Moses, K L Brigham, B Meyrick.   

Abstract

Chronic pulmonary hypertension is associated with extensive structural remodeling of the pulmonary arterial bed. The structural changes in the arterial walls include increased production of extracellular matrix components and smooth muscle cell hypertrophy, changes that have been similarly induced by transforming growth factor-beta (TGF-beta) in culture. In the present study, experiments were performed to determine whether TGF-beta is present in sheep lung lymph, and whether TGF-beta levels were altered in an animal model of chronic pulmonary hypertension induced by continuous air embolization. Several standard biological assays for TGF-beta activity were used for these determinations including soft agar assays, inhibition of epithelial cell proliferation, and a TGF-beta-specific radioreceptor assay. In each case, control lung lymph contained high concentrations of TGF-beta (100 ng/ml) which required transient acidification for detection. Samples of lung lymph from hypertensive sheep showed a transient and early two- to threefold increase in concentrations of latent TGF-beta. This activity could be partially blocked by TGF-beta antibodies. These studies indicate that sheep lung lymph contains TGF-beta and that the level of TGF-beta increases early during the development of pulmonary hypertension. Thus, TGF-beta may contribute to the development of the structural changes in the pulmonary arteries that occur during the onset of chronic pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2243124      PMCID: PMC296890          DOI: 10.1172/JCI114862

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Preparation of chronic lung lymph fistulas in sheep.

Authors:  N C Staub; R D Bland; K L Brigham; R Demling; A J Erdmann; W C Woolverton
Journal:  J Surg Res       Date:  1975-11       Impact factor: 2.192

2.  Isolation from murine sarcoma cells of novel transforming growth factors potentiated by EGF.

Authors:  A B Roberts; M A Anzano; L C Lamb; J M Smith; C A Frolik; H Marquardt; G J Todaro; M B Sporn
Journal:  Nature       Date:  1982-02-04       Impact factor: 49.962

3.  Serum contains a platelet-derived transforming growth factor.

Authors:  C B Childs; J A Proper; R F Tucker; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

4.  BALB and Kirsten murine sarcoma viruses alter growth and differentiation of EGF-dependent balb/c mouse epidermal keratinocyte lines.

Authors:  B E Weissman; S A Aaronson
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

5.  Endothelial cells synthesize basic fibroblast growth factor and transforming growth factor beta.

Authors:  R L Hannan; S Kourembanas; K C Flanders; S J Rogelj; A B Roberts; D V Faller; M Klagsbrun
Journal:  Growth Factors       Date:  1988       Impact factor: 2.511

6.  Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.

Authors:  R K Assoian; A Komoriya; C A Meyers; D M Miller; M B Sporn
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

Review 7.  Pulmonary hypertension. Anatomic and physiologic correlates.

Authors:  B Meyrick; L Reid
Journal:  Clin Chest Med       Date:  1983-05       Impact factor: 2.878

8.  Leukocytes are required for increased lung microvascular permeability after microembolization in sheep.

Authors:  M R Flick; A Perel; N C Staub
Journal:  Circ Res       Date:  1981-03       Impact factor: 17.367

9.  Transforming growth factors from neoplastic and nonneoplastic tissues.

Authors:  A B Roberts; C A Frolik; M A Anzano; M B Sporn
Journal:  Fed Proc       Date:  1983-06

10.  Transforming growth factor production by chemically transformed cells.

Authors:  H L Moses; E L Branum; J A Proper; R A Robinson
Journal:  Cancer Res       Date:  1981-07       Impact factor: 12.701

View more
  16 in total

1.  Transforming growth factor-β inhibition attenuates pulmonary arterial hypertension in rats.

Authors:  Aikaterini J Megalou; Chryssoula Glava; Dimitrios L Oikonomidis; Agapi Vilaeti; Maria G Agelaki; Giannis G Baltogiannis; Apostolos Papalois; Antonios P Vlahos; Theofilos M Kolettis
Journal:  Int J Clin Exp Med       Date:  2010-10-23

2.  EP3 receptor deficiency attenuates pulmonary hypertension through suppression of Rho/TGF-β1 signaling.

Authors:  Ankang Lu; Caojian Zuo; Yuhu He; Guilin Chen; Lingjuan Piao; Jian Zhang; Bing Xiao; Yujun Shen; Juan Tang; Deping Kong; Sara Alberti; Di Chen; Shenkai Zuo; Qianqian Zhang; Shuai Yan; Xiaochun Fei; Fei Yuan; Bin Zhou; Shengzhong Duan; Yu Yu; Michael Lazarus; Yunchao Su; Richard M Breyer; Colin D Funk; Ying Yu
Journal:  J Clin Invest       Date:  2015-02-09       Impact factor: 14.808

3.  Transforming growth factor-beta 1 (TGF-beta1) expression in ovine lentivirus-induced lymphoid interstitial pneumonia.

Authors:  B Moreno; C J Woodall; N J Watt; G D Harkiss
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

4.  Transforming growth factor-beta 1 is decreased in remodeling hypertensive bovine pulmonary arteries.

Authors:  M D Botney; W C Parks; E C Crouch; K Stenmark; R P Mecham
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

5.  Role of the TGF-beta/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension.

Authors:  Ari L Zaiman; Megan Podowski; Satya Medicherla; Kimberley Gordy; Fang Xu; Lijie Zhen; Larissa A Shimoda; Enid Neptune; Linda Higgins; Alison Murphy; Sarvajit Chakravarty; Andrew Protter; Pravin B Sehgal; Hunter C Champion; Rubin M Tuder
Journal:  Am J Respir Crit Care Med       Date:  2008-01-17       Impact factor: 21.405

Review 6.  Pathogenic mechanisms of pulmonary arterial hypertension.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  J Mol Cell Cardiol       Date:  2007-09-20       Impact factor: 5.000

7.  Clinical and molecular characterization of a re-established line of sheep exhibiting hemophilia A.

Authors:  C D Porada; C Sanada; C R Long; J A Wood; J Desai; N Frederick; L Millsap; C Bormann; S L Menges; C Hanna; G Flores-Foxworth; T Shin; M E Westhusin; W Liu; H Glimp; E D Zanjani; J N Lozier; V Pliska; G Stranzinger; H Joerg; D C Kraemer; G Almeida-Porada
Journal:  J Thromb Haemost       Date:  2009-11-23       Impact factor: 5.824

8.  The endogenous vascular elastase that governs development and progression of monocrotaline-induced pulmonary hypertension in rats is a novel enzyme related to the serine proteinase adipsin.

Authors:  L Zhu; D Wigle; A Hinek; J Kobayashi; C Ye; M Zuker; H Dodo; F W Keeley; M Rabinovitch
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

9.  Binding of transforming growth factor-beta 1 to methylamine-modified alpha 2-macroglobulin and to binary and ternary alpha 2-macroglobulin-proteinase complexes.

Authors:  S W Hall; J LaMarre; L B Marshall; M A Hayes; S L Gonias
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

10.  Vascular remodeling in primary pulmonary hypertension. Potential role for transforming growth factor-beta.

Authors:  M D Botney; L Bahadori; L I Gold
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.